Key result
In high-risk patients with severe aortic stenosis, bridge-to-decision balloon aortic valvuloplasty allowed 72.6% of surviving patients to be deemed eligible for definitive surgical or transcatheter treatment.
Why the study?
Does balloon aortic valvuloplasty as a bridge-to-decision facilitate definitive treatment selection in high-risk patients with severe aortic stenosis?
Observational (n=202)
No
Does balloon aortic valvuloplasty as a bridge-to-decision facilitate definitive treatment selection in high-risk patients with severe aortic stenosis?
Balloon aortic valvuloplasty serves as an effective bridge-to-decision strategy, enabling nearly three-quarters of high-risk patients with severe aortic stenosis to become eligible for definitive surgical or transcatheter treatment.
Answers are grounded in this paper and cite their sources.
Supports BAV as bridge-to-decision in high-risk severe AS; leaves open need for randomized confirmation of outcomes.
BACKGROUND: Whilst the majority of the patients with severe aortic stenosis can be directly addressed to surgical aortic valve replacement (AVR) or transcatheter aortic valve implantation (TAVI), in some instances additional information may be needed to complete the diagnostic workout. We evaluated the role of balloon aortic valvuloplasty (BAV) as a bridge-to-decision (BTD) in selected high-risk patients. METHODS: Between 2007 and 2012, the heart team in our Institution required BTD BAV in 202 patients. Very low left ventricular ejection fraction, mitral regurgitation grade ≥ 3, frailty, hemodynamic instability, serious comorbidity, or a combination of these factors were the main drivers for this strategy. We evaluated how BAV influenced the final treatment strategy in the whole patient group and in each specific subgroup. RESULTS: Mean logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) was 23.5% ± 15.3%, age 81 ± 7 years. In-hospital mortality was 4.5%, cerebrovascular accident 1% and overall vascular complications 4% (0.5% major; 3.5% minor). Of the 193 patients with BTD BAV who survived and received a second heart team evaluation, 72.6% were finally deemed eligible for definitive treatment (25.4% for AVR; 47.2% for TAVI): 96.7% of patients with left ventricular ejection fraction recovery; 70.5% of patients with mitral regurgitation reduction; 75.7% of patients who underwent BAV in clinical hemodynamic instability; 69.2% of frail patients and 68% of patients who presented serious comorbidities. CONCLUSIONS: Balloon aortic valvuloplasty can be considered as bridge-to-decision in high-risk patients with severe aortic stenosis who cannot be immediate candidates for definitive transcatheter or surgical treatment.
No takes yet. Share an insight, caveat, or question.
Saia et al. (2016) conducted an observational in Severe aortic stenosis (n=202). Balloon aortic valvuloplasty (bridge-to-decision) was evaluated on Proportion of surviving patients deemed eligible for definitive treatment (AVR or TAVI) at second heart team evaluation. In high-risk patients with severe aortic stenosis, bridge-to-decision balloon aortic valvuloplasty allowed 72.6% of surviving patients to be deemed eligible for definitive surgical or transcatheter treatment.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: